Skip to content

Longitudinal characterization of the sensory phenotype of lipohyperplasia dolorosa (LiDo) patients during weight loss and subsequent liposuction.

Longitudinal characterization of the sensory phenotype of lipohyperplasia dolorosa (LiDo) patients during weight loss and subsequent liposuction.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00031411
Enrollment
150
Registered
2023-03-06
Start date
2023-04-11
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lipedema Lipedema, Stage I Lipedema, Stage II Lipedema, Stage III

Interventions

Group 1: Characterization of the sensory phenotype of obese lipohyperplasia dolorosa (LiDo) patients using quantitative sensory testing during weight loss. Group 2: Characterization of the sensory phe

Sponsors

Universität zu Köln
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Generally: female, age between 18-40 years, present signed and irrevoked informed consent. For LiDo patients for weight reduction: medical diagnosis Lipohyperplasia dolorosa (LiDo), coincident obesity BMI > 40, For the weight loss group: study-independent planned weight loss to achieve BMI 40.

Exclusion criteria

Exclusion criteria: Limitation of the ability to communicate (language barrier, cognitive barriers, ...). Diseases affecting the sensory nervous system (e.g. Parkinson's disease, multiple sclerosis, radiculopathy, injuries of nerves innervating the sensory area of different genesis, diabetic polyneuropathy, peripheral polyneuropathies of different genesis, etc.). skin stresses on the areas of measurement topical application of analgesics to the areas of measurement (e.g. plasters, creams, ...) diagnosed coagulation or wound healing disorder other known alteration in pain perception or another diagnosed pain disorder Liposuction already performed prior to study inclusion Pregnancy

Design outcomes

Primary

MeasureTime frame
Characterization of the changes of the different sensory modalities in the clinical phenotype in female patients: QST profiles of all LiDo patients before and after substantial weight reduction. QST profiles of all LiDo patients before and after lymphological liposculpture. QST profiles of obese patients (independent of weight reduction or liposculpture).

Secondary

MeasureTime frame
The correlation of the primary outcome measures with the pain measures recorded in the pain questionnaire: German pain questionnaire of all patients Pain history questionnaire of all LiDo patients before and after weight reduction or liposuction

Countries

Germany

Contacts

Public ContactRebecca Dinnendahl

Universitätsklinikum Köln

rebecca.dinnendahl@uk-koeln.de+49 221 478 42784

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026